Increased concentrations of serum pentosidine in rheumatoid arthritis

Clinical Chemistry

Volumn 44, Issue 2, 1998, Pages 250-255

  Rodríguez García, Javier ^a   Requena, Jesús R ^a,b   Rodríguez Segade, Santiago ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; PENTOSE; PENTOSIDINE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; RHEUMATOID ARTHRITIS; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031910540     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.2.250     Document Type: Article

References (28)

1. Sell DR, Monnier VM. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990;85:380-4.
2. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991;266:11654-60.
3. Baynes JW. The role of oxidative stress in the development of complications in diabetes. Diabetes 1991;40:405-12.
4. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993;91: 2470-8.
5. Beisswenger PJ, Moore LL, Brink-Johnsen T. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 1993;92:212-7.
6. Nagaraj RH, Sell DR, Prabhakaram M, Orthwerth BJ, Monnier VM. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci U S A 1991;88: 10257-61.
7. Odetti P, Fogarty J, Sell DR, Monnier VM. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992;41:153-9.
8. Takahashi M, Kushida K, Kawana K, Ishihara C, Denda M, Inoue T, Horiuchi K. Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin Chem 1993;39:2162-5.
9. Taneda S, Monnier VM. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 1994; 40:1766-73.
10. Takahashi M, Ohishi T, Aoshima H, Kawana K, Kushida K, Inoue T, Horiuchi K. The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 1993;36:664-7.
11. Sell DR, Lane MA, Johnson WA, Masoro EJ, Mock OB, Reiser KM, et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A 1996;93:485-90.
12. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 1992;41:1286-92.
13. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 1994;124:19-30.
14. Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 1996;9:69-77.
15. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836-42.
16. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, et al. Reactive glycosylation end products in diabetic uremia and treatment of renal failure. Lancet 1994;343:1519-22.
17. Hricik DE, Schulak JA, Sell DR, Fogarty JF, Monnier VM. Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int 1993;43:398-403.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Tan EM, Cohen AS, Fries JF Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Halliwell B, Gutteridge JMC. Chronic inflammation and the autoimmune diseases. In: Free radicals in biology and medicine. Oxford: Clarendon Press, 1989:422-38.
21. Anderson MM, Hazen SL, Hsu FF, Heinecke JW. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. J Clin Invest 1997;99:424-32.
22. Anderson MM, Requena JR, Hazen SL, Fu MX, Thorpe SR, Heinecke JW. A pathway for the generation of advanced glycosylation end products by the myeloperoxidase system of activated phagocytes [Abstract]. Circulation 1996;94:1-37.
23. Lunec J, Blake DR. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis. Free Radic Res Commun 1985;1:31-9.
24. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal disease. Kidney Int 1997;51:1170-81.
25. Friedlander MA, Wu YC, Elgawish A, Monnier VM. Early and advanced glycosylation end products: kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 1996;97:728-35.
26. Hörkkö SE, Miller E, Dudl PD, Reaven NJ, Zvaifler R, Terkeltaub SS, et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of low density lipoprotein. J Clin Invest 1996;98:815-25.
27. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, N∈-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions J Biol Chem 1996;271:9982-6.
28. Takahashi M, Kushida K, Ohishi T, Kawana K, Hoshino H, Uchiyama A, Inoue T. Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum 1994;37:724-8.